home / stock / akba / akba quote
Last: | $1.33 |
---|---|
Change Percent: | 1.46% |
Open: | $1.35 |
Close: | $1.33 |
High: | $1.35 |
Low: | $1.31 |
Volume: | 2,537,335 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.33 | $1.35 | $1.33 | $1.35 | $1.31 | 2,537,335 | 04-25-2024 |
$1.37 | $1.37 | $1.37 | $1.4 | $1.35 | 1,507,759 | 04-24-2024 |
$1.37 | $1.38 | $1.37 | $1.41 | $1.35 | 2,082,959 | 04-23-2024 |
$1.36 | $1.37 | $1.36 | $1.4 | $1.34 | 2,006,106 | 04-22-2024 |
$1.36 | $1.35 | $1.36 | $1.38 | $1.31 | 2,956,394 | 04-19-2024 |
$1.39 | $1.37 | $1.39 | $1.435 | $1.33 | 2,562,577 | 04-18-2024 |
$1.39 | $1.4 | $1.39 | $1.42 | $1.36 | 2,944,347 | 04-17-2024 |
$1.4 | $1.38 | $1.4 | $1.425 | $1.32 | 4,129,457 | 04-16-2024 |
$1.39 | $1.42 | $1.39 | $1.45 | $1.39 | 3,897,726 | 04-15-2024 |
$1.46 | $1.52 | $1.46 | $1.54 | $1.42 | 4,105,836 | 04-12-2024 |
$1.53 | $1.55 | $1.53 | $1.55 | $1.47 | 3,154,704 | 04-11-2024 |
$1.56 | $1.58 | $1.56 | $1.62 | $1.52 | 5,435,326 | 04-10-2024 |
$1.54 | $1.5 | $1.54 | $1.56 | $1.47 | 3,604,419 | 04-09-2024 |
$1.53 | $1.48 | $1.53 | $1.54 | $1.42 | 3,751,939 | 04-08-2024 |
$1.49 | $1.51 | $1.49 | $1.56 | $1.48 | 3,657,003 | 04-05-2024 |
$1.51 | $1.47 | $1.51 | $1.6 | $1.46 | 6,193,592 | 04-04-2024 |
$1.49 | $1.59 | $1.49 | $1.59 | $1.43 | 8,636,952 | 04-03-2024 |
$1.58 | $1.55 | $1.58 | $1.6099 | $1.47 | 8,133,112 | 04-02-2024 |
$1.63 | $1.875 | $1.63 | $1.93 | $1.55 | 14,082,255 | 04-01-2024 |
$1.83 | $2.47 | $1.83 | $2.48 | $1.77 | 61,074,372 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Akebia Therapeutics Inc. Company Name:
AKBA Stock Symbol:
NASDAQ Market:
Akebia Therapeutics Inc. Website:
2024-03-28 14:00:02 ET Ed Arce from H.C. Wainwright issued a price target of $6.00 for AKBA on 2024-03-28 12:08:00. The adjusted price target was set to $6.00. At the time of the announcement, AKBA was trading at $1.98. The overall price target consensus is at $7.00 with...
Wednesday, the FDA approved Akebia Therapeutics Inc (NASDAQ:AKBA) Vafseo (vadadustat) tablets for anemia due to chronic kidney disease (C...
2024-03-28 13:30:02 ET H.C. Wainwright analyst issues BUY recommendation for AKBA on March 28, 2024 12:08PM ET. The previous analyst recommendation was Buy. AKBA was trading at $2.0093 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...